Delaware Attorney General Kathy Jennings is suing several drug manufacturers and pharmacy benefit managers for reported ...

Switzerland-based Sandoz, a global leader in affordable medicines, today confirmed that the European Commission has granted ...

SaveHealth reports that insulin therapy is crucial for diabetes management, with various options available, including rapid- ...

CivicaScript®, LLC, a nonprofit company dedicated to bringing low-cost generic medicines and biosimilars to U.S. patients, today announced the availability of two new products: insulin glargine-yfgn ...

CivicaScript, a nonprofit generic drug company, has launched insulin glargine-yfgn and ustekinumab-aauz, expanding its national portfolio of low-cost treatments. The insulin product, which is ...

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. The nonprofit Civica will develop a ...

A 26-week trial reveals that metformin, long viewed as a promising add-on therapy, lowers insulin needs but leaves tissue-level insulin resistance unchanged. Study: Effect of metformin on insulin ...

If you’re on insulin to treat type 1 or type 2 diabetes, it’s critical to know exactly how to use it. “Insulin can be a very dangerous drug if used improperly,” says Stanley Mathew, MD, an ...

Civica plans to distribute its insulin glargine to pharmacies across the United States for $45 for a box of five pens. “Through the partnership we formed with Civica more than six years ago, BCBSA and ...

Prescriptions for the insulin glargine biosimilar Semglee increased after it was granted interchangeable status with its reference product, Lantus. Increases were seen across retail, mail order, and ...

Utah-based Civica will begin selling a type of long-acting insulin on Jan. 1, 2026, although it will not come from the nonprofit drug maker’s Petersburg facility. Civica announced Thursday it has ...

Starting next year, Californians with diabetes will be able to purchase state-branded insulin at steeply reduced prices, Gov. Gavin Newsom announced today. Long-acting insulin pens will be available ...